TAG:
cost of lab
Sarasota Hospital Lab Reduces Number of Hemolyzed Specimens
By Joseph Burns | From the Volume XIX No. 7 – May 14, 2012 Issue
CEO SUMMARY: Seeking to improve turnaround time for stat lab tests, the laboratory at Sarasota Memorial Health Care System identified high rates of hemolysis as the chief reason for less than ideal TAT. Because 32% of blood draws were handled by the lab’s phlebotomy staff while 68% of b…
Hospital Labs Feel More Pressure to Lower Prices
By Robert Michel | From the Volume XIX No. 5 – April 2, 2012 Issue
CEO SUMMARY: It’s a new trend and gathering momentum. At managed care contract renewal time, more hospitals and health systems report much stronger pressure from health insurers to accept deep cuts to laboratory test prices. At the same time, managed care companies are getting smarter a…
MedTox, Cleveland Clinic Labs, Apollo PACS, Dell, British Columbia Health
By Robert Michel | From the Volume XIX No. 3 – February 20, 2012 Issue
GENOME SEQUENCING TO BE OFFERED BY NORWAY IN NATIONAL HEALTH PLAN HERE’S A MILESTONE ON THE PATH TO PERSONALIZED MEDICINE. Norway is the first nation to announce that its national health system will incorporate whole genome sequencing. Cancer is the target of Norway’s f…
Rhode Island Lab Educates Consumers about Lab Prices
By Robert Michel | From the Volume XVIII No. 12 – September 6, 2011 Issue
TWIN TRENDS NOW CREATE an opportunity for clinical labs and pathology groups to build market share. But tapping these new buyers of laboratory tests will require labs to communicate more effectively with consumers. One trend is the growth in enrollment in health plans that require higher deductibles…
Calif. Officials Back Off From Suspending Labs
By Joseph Burns | From the Volume XVII No. 18 – December 27, 2010 Issue
CEO SUMMARY: Early in the summer, California’s Department of Health Care Services (DHCS) delivered letters to between 10 and 30 laboratory companies notifying them that, effective immediately, it was withholding their Medi-Cal payments and was suspending each lab’s Medi-Cal l…
Irish Labs Are at an Important Crossroads
By R. Lewis Dark | From the Volume XVII No. 7 – May 10, 2010 Issue
GLOBAL OUTSOURCING OF CLINICAL LABORATORY TESTING IN IRELAND has entered its second phase. The Irish Health Service Executive (HSE) granted Quest Diagnostics Incorporated a contract for an additional two-years of cervical cancer screening tests while…
Less Money for Labs Is International Trend
By R. Lewis Dark | From the Volume XVI No. 13 – September 21, 2009 Issue
TOO OFTEN THESE DAYS, labs are asked to accept less money. This is true in the United States and in many developed countries around the world. Many of you know that the latest version of the Senate health reform bill recently released by Max Baucus (D-Montana) calls for all providers to pay a “fee…
Hospitals Saw Several Benefits In Forming Laboratory Joint Venture
By Robert Michel | From the Volume XV No. 3 – March 3, 2008 Issue
CEO SUMMARY: For the past eight years, growing numbers of hospitals and health systems have launched laboratory outreach programs. Hospital CEOs are recognizing that laboratory outreach programs generate worthwhile operational gains, along with steadily-increasing revenues. However, labor…
LabCorp & Sunrise CEOs Score at Exec War College
By Robert Michel | From the Volume XIV No. 7 – May 14, 2007 Issue
CEO SUMMARY: This year’s Executive War College on Lab and Pathology Management delivered major surprises, along with first news of breakthrough innovations and emerging trends. Managed care contracting for lab testing services was this year’s premier topic and there was keen interest …
Aetna Says: LabCorp Is Out & Quest Diagnostics Is In
By Robert Michel | From the Volume XIV No. 4 – March 12, 2007 Issue
CEO SUMMARY: January 1, 2007 can be considered the start of a new epoch in managed care contracting for lab test services. News of Aetna’s decision to favor Quest Diagnostics Incorporated with a five-year contract as its only national laboratory provider shows the direction this new epo…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized